Report: Lack of Biosimilar Competition Contributed to Billions in Lost Savings

September 21, 2020

The United States has missed out on almost $20 billion in savings as a result of not having a competitive biosimilar market, according to findings from the Pacific Research Institute.

Rugo Wins Prestigious Giants of Cancer Care® Award
Lotus Inks Deal With CKD to Distribute Darbepoetin Alpha Biosimilar
Not So Different: Rep Grothman on His Bill to Make Biosimilar Insulins Interchangeable
Contributor: Drug Delivery Devices Help Originator Companies Retain Market Share